A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
for Lymphoma
Drug: Glofitamab
18 locations incl. Berkeley
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06084936·Phase 3·Recruiting